Jan Basile
Internal Medicine · Charleston, SCNPI 1841394475
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $203,855 of the $277,935 with a category attached, or 73.3%. 21 manufacturers reported payments, led by Eli Lilly at 53.1% of the total. Reporting peaked in 2024 at $99,472 and has fallen 58.5% since, to $41,247 in 2025. Among internal medicine clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 338 payments — averaging $822.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$148K
- Novo Nordisk$44K
- Medtronic$28K
- Corcept Therapeutics$22K
- Blue Earth Diagnostics$13K
- Idorsia Pharmaceuticals US Inc$5K
- plus $18K from 15 others
Across 21 payments — averaging $936.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$10K
- Eli Lilly$8K
- Corcept Therapeutics$1K
What the payments were for
- Consulting fees$203,85573%
- Speaking & faculty fees$22,4778%
- Travel & lodging$43,90716%
- Food & beverage$7,4333%
- Education$2630%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 164 | $147,608 |
| Novo Nordisk | 31 | $43,581 |
| Medtronic | 41 | $27,602 |
| Corcept Therapeutics | 34 | $22,069 |
| Blue Earth Diagnostics | 1 | $13,300 |
| Idorsia Pharmaceuticals US Inc | 5 | $5,411 |
| Janssen Scientific Affairs, LLC | 2 | $5,087 |
| Vifor Pharma, Inc. | 9 | $4,973 |
| AstraZeneca | 7 | $4,364 |
| Recor Medical Inc | 3 | $2,465 |
| Amgen | 3 | $476 |
| Edwards Lifesciences | 1 | $186 |
| Esperion Therapeutics, Inc. | 2 | $133 |
| Lilly USA, LLC | 8 | $129 |
| Sanofi-aventis U.S. LLC | 7 | $129 |
| Novartis | 8 | $126 |
| Bayer | 6 | $108 |
| Alnylam Pharmaceuticals Inc. | 1 | $62 |
| Boehringer Ingelheim | 2 | $62 |
| Merck | 2 | $52 |
| Ablative Solutions, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$277,935 in reported general payments places this provider in the 95th percentile of 1,498 internal medicine providers in South Carolina.
Other internal medicine in Charleston
- John CleekCharleston$136K
- Leonard AlsfeldCharleston$91K
- Brett TomashitisCharleston$36K
- Scott SandsCharleston$25K
- Laura KinneyCharleston$20K
- Andrew SchreinerCharleston$15K
- Hardik PatelCharleston$15K
- Mithunan MaheswaranathanCharleston$14K
- Frances HughesCharleston$11K
- Molly McVeyCharleston$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.